FACULTY

Shubham Pant, MD, MBBS
Professor, Department of Gastrointestinal Medical Oncology
and Department of Investigational Cancer Therapeutics
The University of Texas MD Anderson Cancer Center
Houston, TX

PROGRAM OVERVIEW 

This activity brings to life the unique mechanisms of action of bispecific antibodies, including novel, HER2-directed, biparatopic bispecific antibodies being studied for HER2-overexpressing biliary tract cancers (BTCs) and gastroesophageal adenocarcinomas (GEAs). This immersive 3D animation also reviews current and emerging treatment approaches for HER2-positive BTCs and GEAs, as well as efficacy and safety data from relevant clinical trials.

TARGET AUDIENCE 

This activity is designed to educate global oncologists and other multidisciplinary health care professionals treating patients with HER2 overexpressing GEA and BTC.

LEARNING OBJECTIVES 

Upon the completion of this program, attendees should be able to:

• Assess global data informing the assessment of HER2 expression assessment in GEA and BTC.
• Describe the basis for guideline recommendations in the management of HER2-positive GEA and BTC.
• Analyze clinical trial findings involving treatments targeting HER2 in GEA and BTC to inform second-line management.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION 

Med Learning Group designates this activity for a maximum of 0.50 ANCC contact hour.

DISCLOSURE POLICY STATEMENT 

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S) 

All relevant financial relationships have been mitigated. 

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity 

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Shannon Mutch MS, RN, OCN, has nothing to disclose.
• Michael Milano, MD, Has received royalties from Wolters Kluwer (UpToDate author royalties).
• Kim L. Farina, PhD, Medical Director for Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Daniela DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
• Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity.

In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.

Your certificate will be provided as a downloadable file.

DISCLAIMER 

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (dietary, physical, etc).  Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

RELEASED DATE: August 02, 2024
EXPIRATION DATE: August 02, 2025

Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.